Stock MOLN MOLECULAR PARTNERS AG
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Molecular Partners AG

Equities

MOLN

CH0256379097

Market Closed - Swiss Exchange
Other stock markets
 11:31:30 2024-04-26 am EDT 		5-day change 1st Jan Change
3.36 CHF +5.00% Intraday chart for Molecular Partners AG -0.30% -2.33%
Mar. 15 Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024
Mar. 15 Molecular Partners Swings to Loss in FY23; Revenue Down MT

Evolution of the average Target Price on Molecular Partners AG

Price target over the last 5 years

History of analyst recommendation changes

03de553cb1.SQGBdXUxhZCrvVPGfnVy4Blxu3b_OvLhkOgSr2LEKYk.O1H1JSNQ6P_g6GOBOhMq0Fsi90OFcMep5o1U-y7wQ_oGcPgdAXjSpp6NCg~0abaf04351a885aa06562a090a6aba40

Analyst Recommendations on Molecular Partners AG

JPMorgan Cuts Molecular Partners Price Target to $4.50 From $6.60, Maintains Neutral Rating MT
SVB Securities Downgrades Molecular Partners to Market Perform From Outperform, Adjusts Price Target to $8 From $30 MT
Credit Suisse Cuts Price Target on Molecular Partners to CHF6 From CHF8, Lowers Probability of Success for Ensovibep to 5%, Keeps Neutral Rating MT
Credit Suisse Upgrades Molecular Partners to Neutral from Underperform MT
Credit Suisse Upgrades Molecular Partners to Neutral From Underperform, Cuts Price Target to CHF8 From CHF10 MT
SVB Leerink Adjusts Price Target on Molecular Partners to $29 From $42, Keeps Outperform Rating MT
Molecular Partners Downgraded by Credit Suisse to Underperform From Neutral, Price Target Cut to CHF10 From CHF23; Shares Drop 38% as Novartis Says More Ensovibep Data May Be Needed MT
Kempen Downgrades Molecular Partners to Neutral From Buy, Sets $10 Price Target MT
Credit Suisse Boosts Price Target on Molecular Partners to CHF23 From CHF17, Citing 'Strong' Data on COVID-19 Antiviral Candidate Ensovibep; Neutral Kept MT
SVB Leerink Adjusts Molecular Partners' Price Target to $42 from $35, Keeps Outperform Rating MT
ANALYST RECOMMENDATIONS : Acceleron Pharma, General Mills, Southwest Airlines, Home Depot, Wizz Air... Our Logo
MOLECULAR PARTNERS' : Price Target From Credit Suisse Cut to CHF17 From CHF18.50 Amid Data Delay for COVID-19 Treatment Candidate MT
ANALYST RECOMMENDATIONS : Allegiant Travel, Electronic Arts, Molecular Partners, Radware, Virgin Galactic... Our Logo
ANALYST RECOMMENDATIONS : American Express, HSBC, CyrusOne, Microsoft, Vodafone... Our Logo
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.2 CHF
Average target price
9.35 CHF
Spread / Average Target
+192.19%
High Price Target
15 CHF
Spread / Highest target
+368.75%
Low Price Target
3.7 CHF
Spread / Lowest Target
+15.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Molecular Partners AG

JPMorgan Chase
SVB Securities LLC
Credit Suisse
Kempen
SVB Leerink

Ratings for Molecular Partners AG

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MOLN Stock
  4. Consensus Molecular Partners AG